


The Invesco Perpetual UK Strategic Income Fund aims to produce an above average income with capital growth primarily through a portfolio of investments in UK companies.
| Name | % Net Assets |
|---|---|
| BT | 5.6% |
| British American Tobacco | 5.0% |
| Imperial Tobacco | 4.7% |
| GlaxoSmithKline | 4.4% |
| Vodafone | 4.3% |
| Reynolds American | 4.3% |
| BG | 4.1% |
| AstraZeneca | 3.9% |
| BAE Systems | 3.6% |
| Roche | 3.5% |
| Key | % Net Assets |
|---|---|
| 5.6% | |
| 5.0% | |
| 4.7% | |
| 4.4% | |
| 80.3% |
| Date | 31-Jul-2020 |
|---|---|
| NAV | 79.54p |
| Currency | GBP |
| Change | -0.030p |
| % | -0.04% |
| YTD change | 79.54p |
| YTD % | n/a |
| Fund Inception | 25/06/1971 |
|---|---|
| Fund Manager | Mark Barnett |
| TER | 1.69 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.67% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research